NCT07128888 - Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 17, 2025

Primary Completion Date

July 5, 2026

Study Completion Date

July 5, 2026

Conditions

Obesity or Overweight

Interventions

DRUG

GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets

GZR18 injection: 3 mg-36 mg，16 weeks; Warfarin Sodium Tablets:2.5mg，twice; Rosuvastatin Calcium Tablets：10mg，twice; Digoxin Tablets:0.25mg，twice

Trial Locations (1)

Study site 01, Beijing